Switch to
More onapp

Dr Habeebullah Life Sciences Ltd

SAMSRITA
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹40 cr, stock is ranked 2,758
High RiskStock is 3.42x as volatile as Nifty
29.601.70 (+6.09%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹40 cr, stock is ranked 2,758
High RiskStock is 3.42x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
27.32
PB RatioPB Ratio
3.08
Dividend YieldDiv. Yield
Sector PESector PE
35.90
Sector PBSector PB
4.36
Sector Div YldSctr Div Yld
0.88%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Dr Habeebullah Life Sciences Limited is an India-based biopharma company. The Company is engaged in research and development (R&D), trading, import and exports, and R&D services of bioproducts and pharma products. The Company's products and R&D include Stem Cell R&D, New Drug Discovery, ribonucleic acid (RNA) Interference, Molecular Biomarkers and Medical Devices. Its Stem Cell R&D division specializes in stem cell research and therapy, regenerative medicine, bio-artificial organ scaffolds development, nanobiotechnology, nano formulation of cancer drugs, molecular genetics, and molecular virology, stem cell and cord blood banking. Its New Drug Discovery division is focused on working on five therapeutic areas of Wilson’s disease, non-alcoholic steatohepatitis (NASH), neuropathic pain, cardiovascular diseases, cystinosis and Huntington's disease. Its services include molecular diagnostics, stem cell therapy, clinical services, contract research organization and academic services.

Financial TrendFinancial statements 

20192020202120222.011.590.161.93-2.34-1.99-0.771.49
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Hmm, looks like data is unavailable here. Please come back after some time
See all events